Crinetics Pharmaceuticals (CRNX) Non-cash Items (2018 - 2025)

Crinetics Pharmaceuticals has reported Non-cash Items for 8 years, with the latest figure at $7.5 million in Q2 2025.

• For the quarter ending Q2 2025, Non-cash Items rose 28.52% year-over-year to $7.5 million; the trailing twelve-month figure through Jun 2025 stood at $7.5 million (up 28.52% YoY), and the FY2024 full-year result was $6.5 million, up 23.27% from the prior year.
• Non-cash Items for Q2 2025 stood at $7.5 million, up from $7.0 million in the prior quarter.
• The five-year high for Non-cash Items was $4.1 billion in Q4 2022, with the low at $2172.0 in Q1 2021.
• Average Non-cash Items over 5 years is $283.0 million, with a median of $6.7 million recorded in 2024.
• Year-over-year, Non-cash Items tumbled 99.99% in 2021 and surged 979328.37% in 2022.
• Tracing CRNX's Non-cash Items over 5 years: stood at $43.4 million in 2021, then surged by 9399.11% to $4.1 billion in 2022, then sank by 99.87% to $5.3 million in 2023, then rose by 23.27% to $6.5 million in 2024, then climbed by 15.0% to $7.5 million in 2025.
• The last three Non-cash Items figures came in at $7.5 million (Q2 2025), $7.0 million (Q1 2025), and $6.5 million (Q4 2024), per Business Quant data.

Peer Comparison